What Molecular and Genetic Testing Labs Need to Know to Succeed with Commercialization of Their Precision … – DARKDaily.com – Laboratory News

Webinar Wednesday,March22, 2017 at 1:00 PM EDT Gaining Network Status, Demonstrating Clinical Utility, Marketing to Cash Buyers, and Other Essentials

One of healthcares unheralded stories is good news for molecular and genetic testing laboratories, along with hospital/health system labs that already have instruments capable of performing these tests! Day-by-day, ever more physicians begin to include elements of precision medicine in their clinical practice, thus requiring them to use molecular and genetic tests.

Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a diagnostic test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.

These are just two reasons why it is imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine. Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Thats why labs need a strategy that addresses these elements:

1) Which type of precision medicine tests will the lab emphasize?

2) Can it run these tests on existing lab analyzers, or will it need to acquire new instruments?

3) Are there existing physician-champions of precision medicine in the labs service area who are respected as clinical leaders and willing to share their patient care successes with colleagues?

4) Can the lab profitably collaborate/partner with labs and companies that already have proven assays, robust informatics capabilities, and similar tools needed to provide tests that support precision medicine?

5) Are there payers in the labs regional market that have existing coverage guidelines for the types of precision medicine tests the lab wants to provide? Are the targeted types of precision medicine tests covered by existing managed care contracts?

These important questions about strategy will be among the topics to be covered at what may be the most important webinar about precision medicine lab testing that has yet been delivered to the clinical laboratory industry. The webinar is titled, What Molecular and Genetic Testing Labs Need to Know to Succeed with Commercialization of Their Precision Medicine Products, and takes place Wednesday, March 22, at 1 PM EDT.

Your experts will emphasize the two vital success factors for a labs precision medicine test program. For the clinical and operational issues involved in selecting, performing, reporting, and business development to generate specimen referrals, the speakers are Don Rule, CEO, and Yoav Sibony, Vice President of Sales & Marketing, at Translational Software in Bellevue, WA. Translational Software currently provides a full range of services to more than 80 client labs and health organizations that includes annotating and analyzing molecular and genetic test data, helping labs define genetic panels relevant to the labs clinicians and augmenting existing panels with interpretation, plus other capabilities.

Next, for the important issue of how to get paid for your labs molecular and genetic tests, the speaker is Kyle Fetter, Vice President of Advanced Diagnostics at XIFIN, Inc. in San Diego, CA. XIFIN is one the nations largest providers of revenue cycle management services to clinical laboratories, pathology groups, and molecular/genetic testing companies.

Fetter brings an informed perspective to the topic of helping your lab get paid because XIFIN handles several hundreds of millions of lab test claims for its client labs each year. It has electronic interfaces with every health insurance plan in the United States and thus knows the coverage guidelines and criteria needed for molecular and genetic test claims to be successfully adjudicated and reimbursed to the submitting molecular and genetic testing lab company.

And theres more! Hospital and health system labs are in for a positive surprise. During his presentation, Rule will discuss how existing lab instruments can be used to perform precision medicine testing, thus giving hospital labs a way to generate more specimen referrals while becoming an essential clinical partner with physicians in the inpatient, outreach, and outpatient settings.

Indeed, you and your lab team will be gaining information from three experts with deep experience in the still-young clinical market for precision medicine testing. You will hear up-to-the-minute reports about which areas of precision medicine are growing fastest, including cancer testing and pharmacogenomic testing.

As an added bonus, at the conclusion of the presentation there will be a Q&A period during which youll be able to submit your own specific questions to our expert panel. This segment of the webinar represents particularly high value for you and your lab team!

DATE: Wednesday, March 22, 2017

TIME: 1 PM EDT; 12 Noon CDT; 10 AM PDT

PLACE: Your computer and/or speakerphone

COST:$195 per site (unlimited attendance per site) through 3/10/17, $245 thereafter

TO REGISTER: Click here or call512-264-7103

Youll come away from this webinar with powerful insights about specific types of precision medicine tests that have accepted clinical evidence of utility and are thus becoming a standard of care. These are also the tests for which payers will most readily reimburse when utilized appropriately by physicians.

How to Register:1. Online 2. Call 512-264-7103.

Your orderincludes:

She is a member of DxMA, ASM and AMP and was a Microbiology Supervisor before transitioning to the diagnostic industry.